Skip to main content

Sernova Corp(SVA-T)
TSX

Today's Change
Real-Time Last Update

Sernova: Top 10 Undervalued Biotechnology Industry Stocks (SVA)

The Globe and Mail - Sun Nov 27, 2022
Industry Group

Sernova is now ranked among the top 10 undervalued stocks in the Biotechnology industry on the Toronto Stock Exchange or TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company. Valuation methodology provided by Stockcalc (see below).

Biotechnology: Biotech and biopharmaceutical companies engaged in research, discovery, development, and production of innovative drug and drugrelated technologies. Stocks in this category are held primarily for capital appreciation.

SymbolNameClose Price ($)Valuation ($)DifferenceAverage Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
VXL-XVaxil Bio0.010.030.02
(114.09)
71,0752.100
IBO-XUniversal Ibogaine0.030.080.05
(204.46)
207,6534.800
AEZS-TAEterna Zentaris5.0211.236.21
(123.62)
1,57024.400
WAVE-XWaverley Pharma0.040.090.05
(112.74)
4,0622.200
APC-XAdvanced Proteome0.040.120.08
(175.71)
5,6321.801.1
KNE-XKane Biotech0.090.170.08
(89.88)
94,75010.500
PAS-XPascal Biosciences0.020.040.02
(99.34)
5,4311.300
ACST-XAcasti Pharma0.551.510.96
(174.18)
1,63924.500
SVA-TSernova0.771.390.62
(81.13)
91,392208.100
RP-XRepliCel Life Sciences0.090.160.07
(77.78)
7,3083.200

More about Sernova

All data provided as-at market close November 24, 2022. The list is sorted by stocks with the greatest percentage difference between valuation and price. Sernova Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. Sernova is listed under SVA on the Toronto Stock Exchange.

Stockcalc

StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs. StockCalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. StockCalc's Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including: Discounted Cash Flow (DCF), Price & Other Comparables, Multiples, Adjusted Book Value (ABV) and Analyst Consensus

Artificial intelligence at Report on Business

Artificial Intelligence at Report on Business Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.

More from The Globe